A Study to Evaluate ALN-XDH in Healthy Subjects and Patients With Gout
Clinical trial NCT05256810 · TERMINATED
Trial details
- NCT number
- NCT05256810
- Sponsor
- Alnylam Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-25
- Primary completion
- 2023-01-25
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.